:: Volume 33, Issue 3 And 4 (10-2021) ::
J Iran Dent Assoc 2021, 33(3 And 4): 58-67 Back to browse issues page
In Vitro Evaluation of a New Combination of Three Antibiotic Paste Against Common Endodontic Pathogens
Prasanna Dahake1 , Nilima Thosar * 2
1- Ph. D. Student, Faculty of Dental Sciences, Department of Pedodontics, Sharad Pawar Dental College and Hospital, DMIMS (Deemed to be University) - Sawangi (M), Wardha, Maharashtra, India
2- PhD, MDS Department of Pedodontics and Preventive Dentistry, Sharad Pawar Dental College and Hospital, DMIMS (Deemed to be University) - Sawangi (M), Wardha, Maharashtra, India
Abstract:   (1464 Views)
Background and Aim: Removing the pathogenic microorganisms from the root canal system is the key to a successful endodontic therapy. This study aimed to evaluate the antibacterial efficiency of three antibacterial agents and a new combination against selected endodontic pathogens.
Materials and Methods: In this in vitro study, the efficacy of three different antibacterial agents namely clindamycin, metronidazole, doxycycline, and their com-bination (CMD) was evaluated against seven bacterial strains associated with endo-dontic infections to determine their minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). selective media were used to culture Candida albicans (C. albicans), Pseudomonas aeruginosa (P. aeruginosa), Escherichia coli (E. coli), Enterococcus faecalis (E. faecalis), Streptococcus mutans (S. mutans), Bacillus subtilis (B. subtilis) subsp. spizizenii, and Actinomyces actinomycetemcomitans (A. actinomycetemcomitans). All the tests were repeated in triplicate. The MIC and MBC values were reported as mean ± standard deviation. Data were analyzed by the Shapiro-Wilk test, the Kruskal-Wallis test, and Wilcoxon signed-rank test (P<0.05).
Results: The intergroup comparisons of MIC for clindamycin versus CMD (P=0.036), metronidazole versus CMD (P=0.016), and doxycycline versus CMD (P=0.016) demonstrated significant differences. No other significant difference was noted (P>0.05). Intergroup comparisons of MBC for clindamycin versus CMD (p=0.036), metronidazole versus CMD (P=0.022), and doxycycline versus CMD (p=0.016) demonstrated significant differences. No other significant difference was noted (P>0.05).
Conclusion: CMD showed superior antibacterial efficacy than each individual antibiotic, and can be used effectively against the abovementioned endodontic patho-gens for their predictable elimination during endodontic therapy.
Keywords: Anti-Bacterial Agents, Clindamycin, Doxycycline, Metronidazole, Root Canal Therapy
Full-Text [PDF 548 kb]   (274 Downloads)    
Type of Study: Orginal | Subject: Porosthodontics
References
1. Casadevall A, Pirofski L. Host-pathogen interactions: the attributes of virulence. J Infect Dis. 2001 Aug;184(3):337-44.
2. Koo H, Allan RN, Howlin RP, Stoodley P, Hall-Stoodley L. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol. 2017 Dec;15(12):740-55.
3. Gabrilska RA, Rumbaugh KP. Biofilm models of polymicrobial infection. Future Microbiol. 2015;10(12):1997-2015.
4. Peterson SN, Snesrud E, Liu J, Ong AC, Kilian M, Schork NJ, et al. The dental plaque microbiome in health and disease. PLoS One. 2013;8(3): e58487.
5. van Houte J, Lopman J, Kent R. The predominant cultivable flora of sound and carious human root surfaces. J Dent Res. 1994 Nov;73(11):1727-34.
6. Ghabraei S, Bolhari B, Sabbagh MM, Afshar MS. Comparison of Antimicrobial Effects of Triple Antibiotic Paste and Calcium Hydroxide Mixed with 2% Chlorhexidine as Intracanal Medicaments Against Enterococcus faecalis Biofilm. J Dent (Tehran). 2018 May;15(3):151-60.
7. Gilad JZ, Teles R, Goodson M, White RR, Stashenko P. Development of a clindamycin-impregnated fiber as an intracanal medication in endodontic therapy. J Endod. 1999 Nov; 25(11):722-7.
8. Neelakantan P, Romero M, Vera J, Daood U, Khan AU, Yan A, et al. Biofilms in Endodontics-Current Status and Future Directions. Int J Mol Sci. 2017 Aug;18(8):1748.
9. Yoo YJ, Perinpanayagam H, Oh S, Kim AR, Han SH, Kum KY. Endodontic biofilms: contemporary and future treatment options. Restor Dent Endod. 2019 Jan 31;44(1):e7.
10. Panpaliya NP, Dahake PT, Kale YJ, Dadpe MV, Kendre SB, Siddiqi AG, et al. In vitro evaluation of antimicrobial property of silver nanoparticles and chlorhexidine against five dif-ferent oral pathogenic bacteria. Saudi Dent J. 2019 Jan;31(1):76-83.
11. Qaiyumi S. Macro and microdilution methods of antimicrobial susceptibility testing. In: Schwabe R, Steele-Moore L, Goodwil AC. (Eds.), Antimicrobial Susceptibility Testing Protocols. CRC Press, United State of America. 2007: pp 75-9.
12. Espinel-Ingroff A, Colombo AL, Cordoba S, Du-fresne PJ, Fuller J, Ghannoum M, et al. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method. Antimicrob Agents Chemother. 2015 Dec 7;60(2):1079-84.
13. Segura-Egea JJ, Gould K, Şen BH, Jonasson P, Cot-ti E, Mazzoni A, et al. Antibiotics in Endodontics: a review. Int Endod J. 2017 Dec; 50(12):1169-84.
14. Liljemark WF, Bloomquist C. Human oral mi-crobial ecology and dental caries and periodontal diseases. Crit Rev Oral Biol Med. 1996;7(2):180-98.
15. Sundqvist G, Figdor D, Persson S, Sjögren U. Mi-crobiologic analysis of teeth with failed endodontic treatment and the outcome of conservative re-treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jan; 85(1): 86-93.
16. Radcliffe CE, Potouridou L, Qureshi R, Habahbeh N, Qualtrough A, Worthington H, et al. Antimi-crobial activity of varying concentrations of sodium hypochlorite on the endodontic microorganisms Actinomyces israelii, A. naeslundii, Candida albicans and Enterococcus faecalis. Int Endod J. 2004 Jul; 37 (7):438-46.
17. Molander A, Reit C, Dahlén G, Kvist T. Microbiological status of root-filled teeth with apical periodontitis. Int Endod J. 1998 Jan;31 (1):1-7.
18. Nair PN, Sjögren U, Krey G, Kahnberg KE, Sundqvist G. Intraradicular bacteria and fungi in root-filled, asymptomatic human teeth with therapy-resistant periapical lesions: a long-term light and electron microscopic follow-up study. J Endod. 1990 Dec;16(12):580-8.
19. Yamane K, Ogawa K, Yoshida M, Hayashi H, Nakamura T, Yamanaka T, et al. Identification and characterization of clinically isolated biofilm-forming gram-positive rods from teeth associated with persistent apical periodontitis. J Endod. 2009 Mar;35(3):347-52.
20. Evans M, Davies JK, Sundqvist G, Figdor D. Mechanisms involved in the resistance of Enterococcus faecalis to calcium hydroxide. Int Endod J. 2002 Mar;35(3):221-8.
21. Pereira RS, Rodrigues VAA, Furtado WT, Gueiros S, Pereira GS, Avila-Campos MJ. Microbial analysis of root canal and periradicular lesion associated to teeth with en-dodontic failure. Anaerobe. 2017 Dec; 48:12-18.
22. Garcez AS, Ribeiro MS, Tegos GP, Núñez SC, Jorge AO, Hamblin MR. Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection. Lasers Surg Med. 2007 Jan;39(1):59-66.
23. Nomura R, Ogaya Y, Nakano K. Contribution of the Collagen-Binding Proteins of Streptococcus mutans to Bacterial Colonization of Inflamed Dental Pulp. PLoS One. 2016 Jul 21;11(7):e0159613.
24. Del Fabbro M, Corbella S, Sequeira-Byron P, et al. Endodontic procedures for retreatment of periapical lesions. Cochrane Database Syst Rev. 2016;10(10):CD005511.
25. Mohammadi Z, Abbott PV. On the local applications of antibiotics and antibiotic-based agents in endodontics and dental traumatology.Int Endod J. 2009 Jul;42(7):555-67.
26. Sandor GK, Low DE, Judd PL, Davidson RJ. An-timicrobial treatment options in the management of odontogenic infections. J Can Dent Assoc. 1998 Jul-Aug;64(7):508-14.
27. Cvek M, Cleaton-Jones P, Austin J, Lownie J, Kling M, Fatti P. Effect of topical application of doxycycline on pulp revascularization and periodontal healing in reimplanted monkey incisors. Endod Dent Traumatol. 1990 Aug; 6 (4):170-6.
28. Torabinejad M, Khademi AA, Babagoli J, Cho Y, Johnson WB, Bozhilov K, et al. A new solution for the removal of the smear layer. J Endod. 2003 Mar;29(3):170-5.
29. Chan Y, Chan CH. Antibiotic resistance of patho-genic bacteria from odontogenic infections in Taiwan. J Microbiol Immunol Infect. 2003 Jun;36(2):105-10.
30. Smieja M. Current indications for the use of clindamycin: A critical review. Can J Infect Dis. 1998 Jan;9(1):22-8.
31. Behra-Miellet J, Dubreuil L, Jumas-Bilak E. Anti-anaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. Int J Antimicrob Agents. 2002 Nov;20(5):366-74.


XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 33, Issue 3 And 4 (10-2021) Back to browse issues page